For the quarter ending 2025-09-30, MNKD had $70,388K increase in cash & cash equivalents over the period. $22,515K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 7,985 | 13,826 |
| Stock-based compensation | 4,318 | 12,905 |
| Interest on liability for sale of future royalties | 3,512 | 7,052 |
| Sold portion of royalty revenue | 3,332 | 6,123 |
| Write-off of inventory | 3,277 | 5,058 |
| Depreciation and amortization | 2,061 | 4,193 |
| Loss on foreign currency transaction | 120 | -7,872 |
| Impairment loss on available-for-sale investment | -6,409 | - |
| Net accretion of investments | -567 | -1,678 |
| Amortization of right-of-use assets | 740 | 1,075 |
| Amortization of debt discount and issuance costs | 158 | 218 |
| Accounts receivable, net | -9,759 | 15,338 |
| Inventory | 1,758 | 5,663 |
| Prepaid expenses and other current assets | 6,989 | 5,371 |
| Other assets | 1 | 1,525 |
| Accounts payable | -2,988 | 3,465 |
| Accrued expenses and other current liabilities | -761 | -9,333 |
| Deferred revenue | 1,891 | -7,141 |
| Operating lease liabilities | 46 | -919 |
| Net cash provided by operating activities | 23,640 | 2,573 |
| Purchase of available-for-sale securities | 55,953 | 88,127 |
| Proceeds from maturities of available-for-sale securities | 42,020 | 101,792 |
| Issuance of note receivable | 10,000 | - |
| Purchase of property and equipment | 1,125 | 1,447 |
| Net cash used in investing activities | -25,058 | 12,218 |
| Proceeds from term loan | 75,000 | - |
| Payment of loan issuance costs | 2,347 | - |
| Payments for taxes related to net issuance of common stock associated with restricted stock units and stock options | 743 | 4,393 |
| Principal payments on financing liability | 154 | 376 |
| Proceeds from market price stock purchase plan and employee stock purchase plan | 50 | 1,288 |
| Milestone payment | - | 639 |
| Milestone right agreement payment | 639 | - |
| Net cash provided by (used in) financing activities | 71,806 | -4,120 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 70,388 | 10,671 |
| Cash and cash equivalents at beginning of period | 47,076 | - |
| Cash and cash equivalents at end of period | 128,135 | - |
MANNKIND CORP (MNKD)
MANNKIND CORP (MNKD)